Loading…
Universe Pharmaceuticals INC is projected to decline to $4.47 by 2027, a -15% move from its current price of $5.27. UPC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $4.71 | $5.27 | $5.89 | -0.02% |
| Jul 15 | $4.50 | $5.27 | $6.16 | -0.04% |
| Jul 16 | $4.34 | $5.27 | $6.39 | -0.06% |
| Jul 17 | $4.22 | $5.27 | $6.58 | -0.08% |
| Jul 18 | $4.11 | $5.26 | $6.75 | -0.10% |
| Jul 19 | $4.01 | $5.26 | $6.91 | -0.12% |
| Jul 20 | $3.92 | $5.26 | $7.06 | -0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.92 | $5.26 | $7.06 | -0.15% |
| Week 2 | $3.47 | $5.25 | $7.97 | -0.29% |
| Week 3 | $3.15 | $5.25 | $8.73 | -0.43% |
| Week 4 | $2.91 | $5.24 | $9.44 | -0.58% |
| Week 5 | $2.71 | $5.23 | $10.10 | -0.72% |
| Week 6 | $2.54 | $5.22 | $10.74 | -0.87% |
| Week 7 | $2.40 | $5.22 | $11.36 | -1.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China.
The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements.
The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
UPC trades at $5.35 and has a market capitalization of $3.55M, ranking 5411. It operates in the Healthcare category.
The current technical picture is bullish, with RSI(14) at 50, SMA50 at $3.60 and SMA200 at $3.79. The stock sits above a support level of $2.84 and faces resistance at $12.18, with a 30-day price range of $2.51 to $11.39. Annualized volatility stands at 200%.
Forecasts show a path of earnings-like price movement across years, with 2026 averaging $5.35 and climbing toward 2030 with an average of $6.59, then toward 2050 with an average of $16.95. The maximum forecast prices reach up to $38.98 by 2050, reflecting a long-term upside scenario despite near-term variability.
A major floor 57.4% below — a decisive break under it would weaken the trend.
The nearest floor, 46.1% below — buyers have tended to step in here.
The nearest ceiling, 131.1% above — a clean break opens room to run.
A major ceiling 205.6% above — clearing it would confirm fresh momentum.
Key UPC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of UPC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.75 | Sell | $5.62 | Sell |
| MA 10 | $6.19 | Sell | $5.51 | Sell |
| MA 20 | $4.59 | Buy | $4.94 | Buy |
| MA 50 | $3.65 | Buy | $4.07 | Buy |
| MA 100 | $3.24 | Buy | $3.95 | Buy |
| MA 200 | $3.79 | Buy | $22.00 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.82 | Neutral |
| Stoch RSI (14) | 18.98 | Buy |
| CCI (20) | 25.66 | Neutral |
| Williams %R (14) | -73.98 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 73.36 | Buy |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 26.02 | Neutral |
| TRIX (15) | 2.80 | Buy |
| Awesome (5,34) | 1.73 | Buy |
| Ultimate (7,14,28) | 44.43 | Neutral |
| Momentum (10) | 2.43 | Buy |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 5.33 | Sell |
| ADX (14) | 13.99 | Neutral |
| ATR (14) | 0.86 | Info |
The near-term technical picture is bullish overall, supported by a neutral-to-positive RSI of 50 and steady moving averages. SMA50 stands at $3.60 and SMA200 at $3.79, placing the price interaction around established trend lines. Near-term support is indicated at $2.84, with resistance at $12.18.
The 30-day price range spans $2.51 to $11.39, underscoring meaningful volatility over the month. The asset shows a high annualized volatility of 200%, which contributes to wider swings in short windows and elevated risk and opportunity for traders.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.25 | $5.27 | $7.29 | 0% | Neutral | |
| $3.24 | $4.47 | $6.66 | -15% | Bearish | |
| $2.99 | $4.38 | $6.95 | -17% | Bearish | |
| $3.06 | $4.72 | $7.88 | -10% | Neutral | |
| $4.01 | $6.48 | $11.24 | +23% | Bullish | |
| $4.19 | $7.08 | $12.73 | +34% | Bullish | |
| $3.19 | $5.62 | $10.40 | +7% | Neutral | |
| $3.21 | $5.90 | $11.24 | +12% | Neutral | |
| $3.09 | $5.90 | $11.52 | +12% | Neutral | |
| $2.60 | $5.16 | $10.31 | -2% | Neutral | |
| $2.95 | $6.55 | $14.38 | +24% | Bullish | |
| $7.51 | $16.69 | $38.39 | +217% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.25 | $5.27 | $6.39 | +0.00% |
| August 2026 | $4.10 | $4.97 | $6.27 | -5.68% |
| September 2026 | $4.21 | $5.17 | $6.66 | +4.03% |
| October 2026 | $4.53 | $5.64 | $7.38 | +8.97% |
| November 2026 | $4.45 | $5.60 | $7.44 | -0.66% |
| December 2026 | $4.27 | $5.41 | $7.29 | -3.28% |
Click any year to see its month-by-month UPC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, UPC could reach as high as $7.29, with a base case around $5.27 and support toward $2.25 — roughly 0% from $5.27. A consolidation phase looks the most probable path here.
Expect UPC to range from $3.24 to $6.66 through 2027. The $4.47 average target implies a -15% move from current prices. That is -15% versus the projected 2026 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The UPC price prediction for 2028 points to an average of $4.38 (low $2.99, high $6.95) — a potential decline of -17% on today's $5.27. Expect choppier, lower action through this leg of the cycle.
In 2029, UPC is projected to trade between $3.06 and $7.88, averaging $4.72 — a potential decline of -10% from today's $5.27. That is up +8% on the projected 2028 average. Price action looks broadly range-bound.
Universe Pharmaceuticals INC's 2030 outlook centres on $6.48, within a $4.01 to $11.24 range. That is up +37% on the projected 2029 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, UPC could reach as high as $12.73, with a base case around $7.08 and support toward $4.19 — roughly +34% from $5.27. Momentum favours further upside here.
Expect UPC to range from $3.19 to $10.40 through 2032. The $5.62 average target implies a +7% move from current prices. That is -21% versus the projected 2031 average. A consolidation phase looks the most probable path here.
The UPC price prediction for 2033 points to an average of $5.90 (low $3.21, high $11.24) — a potential gain of +12% on today's $5.27. Price action looks broadly range-bound.
In 2034, UPC is projected to trade between $3.09 and $11.52, averaging $5.90 — a potential gain of +12% from today's $5.27. That is 0% versus the projected 2033 average. A consolidation phase looks the most probable path here.
Universe Pharmaceuticals INC's 2035 outlook centres on $5.16, within a $2.60 to $10.31 range. That is -12% versus the projected 2034 average. That marks a -2% change versus current levels. Price action looks broadly range-bound.
By 2040, UPC could reach as high as $14.38, with a base case around $6.55 and support toward $2.95 — roughly +24% from $5.27. Buyers look set to stay in control over this stretch.
Expect UPC to range from $7.51 to $38.39 through 2050. The $16.69 average target implies a +217% move from current prices. That is up +155% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in UPC today (≈ 189.753321 UPC) could be worth
$3,167
+$2,167 (+217%) by 2050 · US Dollar
Based on the average projected UPC price of $16.69 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in UPCwould be worth at today's price.
$1,000 invested in UPC on Jul 10, 2025 (≈ 265.251991 UPC) would be worth
$1,397.88
+$397.88 (+39.8%) today · 1.40× · US Dollar
Based on a UPC entry price of $3.77 vs. today's $5.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.32 | $833.86 | -16.6% |
| 1 month ago | $3.63 | $1,451.79 | +45.2% |
| 3 months ago | $3.06 | $1,722.22 | +72.2% |
| 6 months ago | $4.16 | $1,266.83 | +26.7% |
| 1 year ago | $3.77 | $1,397.88 | +39.8% |
| All time (5.0y) ago | $9,900 | $0.53 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our UPC forecast.
Our base-case forecast reaches $11.00 around 2050.
Implied market cap at $11.00: $6.95M
In the multi-year forecast, the average price strengthens meaningfully by 2030 to $6.59 with a 23.3 ROI and a bullish sentiment, while 2031 shows an avg of $7.15 and a 33.7 ROI. The trajectory remains mixed through 2032–2035, but remains in neutral-to-bullish territory with 2032 at $5.71 (6.8 ROI) and 2033 at $6.01 (12.3 ROI).
By 2040, the avg price rises to $6.61 with a 23.6 ROI and a bullish sentiment, continuing the longer-term upside. The 2050 forecast shows a substantial jump to an avg of $16.95 with a 217.1 ROI and bullish sentiment, with a max forecast price of $38.98.
Near-term years 2027–2029 depict negative ROIs (-15.1, -17.5, -9.8 respectively), signaling near-term volatility. The longer-term outlook, however, points to meaningful upside potential through 2030, 2040 and especially 2050, albeit with uncertainty and the usual investment risks. These figures are estimates, not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $6.59, with a min of $4.07 and a max of $11.44, and a ROI of 23.3. The sentiment is bullish, indicating an upside path within the forecast range.
Near-term years 2027–2029 show negative ROIs (-15.1, -17.5, -9.8) and bearish-to-neutral sentiment, but the long-term outlook improves with bullish sentiment in 2030, 2040, and 2050 and a rising avg price.
No. The forecast maximums show $11.44 in 2030, $14.51 in 2040, and $38.98 in 2050, far below $150.
The near-term technical picture is bullish with RSI(14) at 50, SMA50 at $3.60, SMA200 at $3.79, and a price setup between support at $2.84 and resistance at $12.18. The 30-day range is $2.51 to $11.39, and volatility is high at 200%.
The current price is $5.35 and the market capitalization is $3.55M, with a rank of 5411.
Universe Pharmaceuticals INC Community Discussion
0Share your Universe Pharmaceuticals INC price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.